Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 5:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 1,132 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: ASD Clear all
Completed Phase 2 Interventional Results available

Cannabidiol for ASD Open Trial

NCT03900923
View directory record Official record
Conditions
ASD, Autism Spectrum Disorder
Interventions
98% pure CBD
Drug
Lead sponsor
NYU Langone Health
Other
Eligibility
7 Years to 17 Years
Enrollment
29 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2023
U.S. locations
1
States / cities
New York, New York
Source: ClinicalTrials.gov public record
Updated May 31, 2024 · Synced Oct 20, 2026, 5:27 PM EDT
Recruiting Phase 2 Interventional Accepts healthy volunteers

Trial of Suvorexant for Sleep in Children With Autism

NCT05546554
View directory record Official record
Conditions
Autism, Autism Spectrum Disorder
Interventions
Suvorexant, Placebo
Drug
Lead sponsor
Stanford University
Other
Eligibility
13 Years to 17 Years
Enrollment
26 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2028
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated Mar 27, 2026 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Not applicable Interventional

Schema, Emotion and Behavior-Based Therapy for School Children

NCT02010086
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Individual Cognitive Behavioral Therapy, Standard Community Treatment
Behavioral
Lead sponsor
University of California, Los Angeles
Other
Eligibility
6 Years to 10 Years
Enrollment
44 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2016
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated Sep 7, 2018 · Synced Oct 20, 2026, 5:27 PM EDT
Recruiting Phase 2 Interventional

TB006 for Autism Spectrum Disorder

NCT06500637
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
TB006
Drug
Lead sponsor
Rossignol Medical Center
Other
Eligibility
18 Years to 35 Years
Enrollment
45 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2024 – 2027
U.S. locations
2
States / cities
Phoenix, Arizona • Aliso Viejo, California
Source: ClinicalTrials.gov public record
Updated Apr 14, 2026 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 4 Interventional Results available

FMRI Brain Activation of Aripiprazole Treatment in Autism Spectrum Disorders

NCT01028820
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Aripiprazole
Drug
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
10 Years to 55 Years
Enrollment
13 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2009 – 2011
U.S. locations
2
States / cities
Chapel Hill, North Carolina • Durham, North Carolina
Source: ClinicalTrials.gov public record
Updated Mar 11, 2014 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 1Phase 2 Interventional Results available

University of California, San Diego (UCSD) Suramin Autism Treatment-1 (SAT1) Trial

NCT02508259
View directory record Official record
Conditions
Autism Spectrum Disorders
Interventions
Suramin, Saline
Drug
Lead sponsor
University of California, San Diego
Other
Eligibility
4 Years to 17 Years · Male only
Enrollment
10 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2015 – 2016
U.S. locations
1
States / cities
La Jolla, California
Source: ClinicalTrials.gov public record
Updated Jul 16, 2019 · Synced Oct 20, 2026, 5:27 PM EDT
Completed No phase listed Observational Results available

Comparison of DSM-IV-TR and DSM-5 for ASD

NCT02296502
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
DSM
Other
Lead sponsor
University of Pittsburgh
Other
Eligibility
2 Years to 17 Years
Enrollment
439 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2014 – 2016
U.S. locations
5
States / cities
Los Angeles, California • Columbia, Missouri • Cincinnati, Ohio + 2 more
Source: ClinicalTrials.gov public record
Updated Mar 11, 2019 · Synced Oct 20, 2026, 5:27 PM EDT
Active, not recruiting No phase listed Observational Accepts healthy volunteers

Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome

NCT02461420
View directory record Official record
Conditions
Phelan-McDermid Syndrome, Autism Spectrum Disorder, Intellectual Disability
Interventions
Not listed
Lead sponsor
Boston Children's Hospital
Other
Eligibility
18 Months and older
Enrollment
207 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2015 – 2026
U.S. locations
5
States / cities
Stanford, California • Chicago, Illinois • Bethesda, Maryland + 2 more
Source: ClinicalTrials.gov public record
Updated Aug 6, 2026 · Synced Oct 20, 2026, 5:27 PM EDT
Not listed No phase listed Observational Accepts healthy volunteers

Detection of ASD at the 1st Birthday as Standard of Care: The Get SET Early Model

NCT02463422
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Not listed
Lead sponsor
University of California, San Diego
Other
Eligibility
12 Months to 36 Months
Enrollment
12,000 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2014 – 2020
U.S. locations
2
States / cities
Phoenix, Arizona • La Jolla, California
Source: ClinicalTrials.gov public record
Updated Mar 2, 2020 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Early Phase 1 Interventional

Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders

NCT02081027
View directory record Official record
Conditions
Autism Spectrum Disorders
Interventions
Riluzole, placebo
Drug · Other
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Other
Eligibility
12 Years to 25 Years
Enrollment
8 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2015
U.S. locations
1
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Jan 14, 2021 · Synced Oct 20, 2026, 5:27 PM EDT
Active, not recruiting Not applicable Interventional

DOD Regulating Together Intervention

NCT05803369
View directory record Official record
Conditions
Autism Spectrum Disorder, Emotion Regulation
Interventions
Regulating Together (RT), Achieving Independence and Mastery in School (AIMS)
Behavioral
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Other
Eligibility
8 Years to 12 Years
Enrollment
144 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2022 – 2026
U.S. locations
1
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Mar 18, 2026 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Not applicable Interventional

Taekwondo for Children With Autism Spectrum Disorder

NCT03912896
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Taekwondo
Behavioral
Lead sponsor
Loma Linda University
Other
Eligibility
7 Years to 11 Years
Enrollment
6 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2020
U.S. locations
1
States / cities
Loma Linda, California
Source: ClinicalTrials.gov public record
Updated Mar 6, 2020 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Not applicable Interventional

Effectiveness and Implementation of a Mental Health Intervention for ASD

NCT02416323
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
AIM HI Training
Other
Lead sponsor
University of California, San Diego
Other
Eligibility
5 Years to 13 Years
Enrollment
609 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2018
U.S. locations
1
States / cities
San Diego, California
Source: ClinicalTrials.gov public record
Updated Jul 9, 2018 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 2 Interventional Results available

A Study of N-Acetyl Cysteine in Children With Autism

NCT00627705
View directory record Official record
Conditions
Autistic Disorder
Interventions
N-Acetyl Cysteine, Placebo - sugar pill
Drug · Other
Lead sponsor
Stanford University
Other
Eligibility
3 Years to 12 Years
Enrollment
43 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2010
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated May 18, 2017 · Synced Oct 20, 2026, 5:27 PM EDT
Recruiting Not applicable Interventional

A Strength-Based Employment Maintenance Program for Individuals on the Autism Spectrum

NCT06255925
View directory record Official record
Conditions
Autism
Interventions
KF-STRIDE® Into Work!
Behavioral
Lead sponsor
Kessler Foundation
Other
Eligibility
14 Years to 26 Years
Enrollment
30 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2023 – 2026
U.S. locations
1
States / cities
East Hanover, New Jersey
Source: ClinicalTrials.gov public record
Updated Mar 10, 2025 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 1 Interventional

NeuroModulation Technique Treatment of Autism

NCT00503191
View directory record Official record
Conditions
Autism, Neurodevelopmental Disorder
Interventions
NeuroModulation Technique
Behavioral
Lead sponsor
NeuroModulation Technique Research Institute
Other
Eligibility
5 Years to 10 Years
Enrollment
18 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2009
U.S. locations
1
States / cities
Dallas, Texas
Source: ClinicalTrials.gov public record
Updated Jan 22, 2014 · Synced Oct 20, 2026, 5:27 PM EDT
Not listed Phase 2 Interventional

Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism

NCT00110708
View directory record Official record
Conditions
Autism, Autistic Disorder, Child Development Disorders, Pervasive, Gastrointestinal Diseases, Signs and Symptoms, Digestive
Interventions
Oralgam (human immunoglobulin)
Drug
Lead sponsor
PediaMed Pharmaceuticals
Industry
Eligibility
2 Years to 18 Years
Enrollment
120 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2005 – 2006
U.S. locations
22
States / cities
Phoenix, Arizona • Sacramento, California • Gainesville, Florida + 17 more
Source: ClinicalTrials.gov public record
Updated Feb 22, 2006 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 4 Interventional Results available

A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

NCT00576732
View directory record Official record
Conditions
Autistic Disorder, Autism
Interventions
Placebo, Risperidone high dose, Risperidone low dose
Drug
Lead sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Industry
Eligibility
5 Years to 17 Years
Enrollment
96 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2010
U.S. locations
20
States / cities
Dothan, Alabama • Phoenix, Arizona • Sacramento, California + 17 more
Source: ClinicalTrials.gov public record
Updated May 9, 2014 · Synced Oct 20, 2026, 5:27 PM EDT
Terminated No phase listed Observational

A Study of the Association Between Autism and Immune Changes in the Brain

NCT01322555
View directory record Official record
Conditions
Autism Spectrum Disorders, Brain Disease, Autism, Healthy Volunteers
Interventions
Not listed
Lead sponsor
National Institute of Mental Health (NIMH)
NIH
Eligibility
18 Years to 45 Years
Enrollment
15 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2011 – 2017
U.S. locations
1
States / cities
Bethesda, Maryland
Source: ClinicalTrials.gov public record
Updated Jul 5, 2018 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

SweetDreams Sleep Study for Children With Autism

NCT04452045
View directory record Official record
Conditions
Autism Spectrum Disorder, Insomnia
Interventions
SweetDreams
Device
Lead sponsor
University of California, San Francisco
Other
Eligibility
12 Months to 60 Months
Enrollment
20 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2020 – 2021
U.S. locations
1
States / cities
San Francisco, California
Source: ClinicalTrials.gov public record
Updated Dec 2, 2025 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Not applicable Interventional

Pivotal Response Treatment Package for Young Children With Autism

NCT02037022
View directory record Official record
Conditions
Autism Spectrum Disorder (ASD), Autism
Interventions
Pivotal Response Treatment Package (PRT-P)
Behavioral
Lead sponsor
Stanford University
Other
Eligibility
2 Years to 5 Years
Enrollment
48 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2013 – 2017
U.S. locations
1
States / cities
Stanford, California
Source: ClinicalTrials.gov public record
Updated Feb 25, 2020 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 3 Interventional Results available

Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder

NCT04174365
View directory record Official record
Conditions
Irritability Associated With Autism Spectrum Disorder (ASD)
Interventions
Brexpiprazole, Placebo
Drug
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Eligibility
5 Years to 17 Years
Enrollment
119 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2019 – 2022
U.S. locations
1
States / cities
Princeton, New Jersey
Source: ClinicalTrials.gov public record
Updated Aug 28, 2025 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 2 Interventional

Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive Behavior

NCT01171937
View directory record Official record
Conditions
Autism
Interventions
Risperidone, Placebo
Drug
Lead sponsor
University of California, Los Angeles
Other
Eligibility
8 Years to 16 Years
Enrollment
41 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2008 – 2016
U.S. locations
1
States / cities
Los Angeles, California
Source: ClinicalTrials.gov public record
Updated May 17, 2022 · Synced Oct 20, 2026, 5:27 PM EDT
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Trial of CM-AT in Children With Autism With All Levels of FCT (The Blum Study)

NCT02410902
View directory record Official record
Conditions
Autism
Interventions
CM-AT, PLACEBO
Drug
Lead sponsor
Curemark
Industry
Eligibility
3 Years to 8 Years
Enrollment
190 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2015 – 2017
U.S. locations
31
States / cities
Phoenix, Arizona • Tucson, Arizona • Little Rock, Arkansas + 28 more
Source: ClinicalTrials.gov public record
Updated May 24, 2023 · Synced Oct 20, 2026, 5:27 PM EDT